RXSIGHT INC's ticker is and the CUSIP is 78349D107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $770,045 | -2.5% | 27,610 | +0.7% | 0.04% | -4.9% |
| Q2 2023 | $789,984 | +42.0% | 27,430 | -17.8% | 0.04% | +28.1% |
| Q1 2023 | $556,278 | +26.4% | 33,350 | -4.0% | 0.03% | +14.3% |
| Q4 2022 | $440,156 | -13.2% | 34,740 | -17.8% | 0.03% | -28.2% |
| Q3 2022 | $507,000 | -12.3% | 42,240 | +2.9% | 0.04% | -23.5% |
| Q2 2022 | $578,000 | +53.7% | 41,050 | +22.7% | 0.05% | +82.1% |
| Q4 2021 | $376,000 | +94.8% | 33,450 | +120.1% | 0.03% | +75.0% |
| Q3 2021 | $193,000 | – | 15,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Divisadero Street Capital Management, LP | 680,000 | $18,965,200 | 5.98% |
| NEXT CENTURY GROWTH INVESTORS LLC | 747,827 | $20,856,895 | 2.27% |
| Parkman Healthcare Partners LLC | 381,331 | $10,635,322 | 1.95% |
| Atika Capital Management LLC | 509,352 | $14,205,828 | 1.86% |
| RA Capital Management | 3,052,796 | $85,142,480 | 1.68% |
| EAM Investors, LLC | 163,168 | $4,550,756 | 0.88% |
| No Street GP LP | 250,000 | $6,972,500 | 0.83% |
| ADVISORY RESEARCH INC | 156,189 | $4,356,112 | 0.60% |
| Lisanti Capital Growth, LLC | 123,205 | $3,436,187 | 0.54% |
| Alpha DNA Investment Management LLC | 20,879 | $582,315 | 0.24% |